EUVIMEDEUVIMED entdecken
Open Access

Systemic delivery of large-scale manufactured Wharton’s Jelly mesenchymal stem cell-derived extracellular vesicles improves cardiac function after myocardial infarction

Michael A Bellio, Rosemeire M Kanashiro-Takeuchi, Lauro Takeuchi, Shathiyah Kulandavelu, Yee-Shuan Lee, Wayne Balkan, Karen C Young, Joshua M Hare, Aisha Khan

The Journal of Cardiovascular Aging · 2022

DOI: 10.20517/jca.2021.21 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Cardiovascular Aging, 2022. Verfasst von Michael A Bellio und 8 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute, Marcus Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Extracellular vesiclesWharton’s Jellymanufacturingmesenchymal stem cellsmyocardial infarction

Autor:innen und Institutionen

  • Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Department of Pediatrics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Division of Neonatology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute
  • Marcus Foundation

Zitieren

APA

Bellio, M. A., Kanashiro-Takeuchi, R. M., Takeuchi, L., Kulandavelu, S., Lee, Y. S., Balkan, W., Young, K. C., Hare, J. M., & Khan, A. (2022). Systemic delivery of large-scale manufactured Wharton’s Jelly mesenchymal stem cell-derived extracellular vesicles improves cardiac function after myocardial infarction. The Journal of Cardiovascular Aging. https://doi.org/10.20517/jca.2021.21

Vancouver

Bellio MA, Kanashiro-Takeuchi RM, Takeuchi L, Kulandavelu S, Lee YS, Balkan W, et al. Systemic delivery of large-scale manufactured Wharton’s Jelly mesenchymal stem cell-derived extracellular vesicles improves cardiac function after myocardial infarction. The Journal of Cardiovascular Aging. 2022. doi:10.20517/jca.2021.21

BibTeX
@article{Bellio2022,
  author = {Bellio, Michael A and Kanashiro-Takeuchi, Rosemeire M and Takeuchi, Lauro and Kulandavelu, Shathiyah and Lee, Yee-Shuan and Balkan, Wayne and Young, Karen C and Hare, Joshua M and Khan, Aisha},
  title = {Systemic delivery of large-scale manufactured Wharton’s Jelly mesenchymal stem cell-derived extracellular vesicles improves cardiac function after myocardial infarction},
  journal = {The Journal of Cardiovascular Aging},
  year = {2022},
  doi = {10.20517/jca.2021.21}
}
Kostenlos starten →